SUMMARY During the course of a prospective serial study over a period of one year, findings compatible with immune-mediated thrombocytolysis accompanied the administration of valproic acid in about half of 45 children with epilepsy. Thrombocytopenia occurred in 15 and neutropenia in 12 patients, but was transient and self-limiting in each. The association is probably one of cause and effect, and it may reflect the structural similarity between valproic acid and constituents of cell membranes.
Circumstantial evidence suggests that thrombocytopenia may result from the administration of valproic acid in clinical practice. '-6 From recent case studies we have surmised that more than one pathogenetic mechanism may exist since, in one patient, thrombocytopenia resolved despite continuing drug administration.7 Thus, in some instances this association may not be one of cause and effect, but rather may reflect the induction of thrombocytopenia by coincidental viral infection.7 8 With a view to resolving these issues, we embarked on a prospective investigation of a group of children who were receiving treatment with valproic acid.
Study design
All patients who were being given valproic acid under the supervision of a single paediatrician (N M) wtre considered to be eligible for study. At 
